Arkolith/Insider Trading/LXRX/Form 4

Debbane Raymond

DirectorLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Feb 25, 2026
Net Buying
Open-Market Buys
$147K
Open-Market Sells
$0
Net Open-Market Flow
$147K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2026Buy(P)100K$1.47$147K1.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062822-26-000032) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML